[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Cardiovascular Complications In Patients Undergoing Lung Transplantation: A National Inpatient Sample Study",
    "section": "",
    "text": "Study Objective: To evaluate the burden and outcomes of cardiovascular complications occurring during lung transplant hospitalization and identify patient- and hospital-level predictors associated with adverse clinical outcomes.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2017 to 2022. The NIS is part of the Healthcare Cost and Utilization Project (HCUP) and provides a stratified sample of inpatient discharges from U.S. community hospitals across all payers.\nCohort Definition: Patients were included if they met the following criteria\n\nAge ≥ 18 years\nUndergoing lung transplant (ICD 10 PCS: 0BYC0Z0, 0BYC0Z1, 0BYC0Z2, 0BYD0Z0, 0BYD0Z1, 0BYD0Z2, 0BYF0Z0, 0BYF0Z1, 0BYF0Z2, 0BYG0Z0, 0BYG0Z1, 0BYG0Z2, 0BYH0Z0, 0BYH0Z1, 0BYH0Z2, 0BYJ0Z0, 0BYJ0Z1, 0BYJ0Z2, 0BYK0Z0, 0BYK0Z1, 0BYK0Z2, 0BYL0Z0, 0BYL0Z1, 0BYL0Z2, 0BYM0Z0, 0BYM0Z1, 0BYM0Z2)\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nMACE (Acute myocardial infarction OR Cardiac arrest OR Cardiac arrest OR Ventricular arrhythmia OR Revascularization OR Mechanical circulatory support)\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2021 ($)\n\nSecondary Outcomes:\n\nAcute myocardial infarction\nIschemic stroke\nVentricular arrhythmia\nCardiogenic shock\nVenous thromboembolism\nMechanical circulatory support\nSepsis\nAcute kidney injury\nNon-home discharge\n\nCovariates for Adjustment: All models adjusted for the following:\n\nDemographics: Age, sex, race, income, insurance, location of patient’s residence, hospital region, and hospital bedsize\nMedical History: Chronic heart failure, diabetes mellitus, hypertension, chronic kidney disease, peripheral vascular disease, liver disease, valvular heart disease, anemia, and pulmonary circulatory disorders, grouped charlson comorbidity index.\n\nStatistical Methods:\n\nUnivariable Analysis:\n\nCategorical variables: Compared using Pearson’s chi-square test with Rao & Scott adjustment\nContinuous variables: Analyzed using the design-based Kruskal–Wallis test, a non-parametric alternative suitable for survey-weighted data\n\nMultivariable Analysis:\n\nBinary outcomes (e.g., mortality): Survey-weighted logistic regression using the quasibinomial family\nContinuous outcomes (e.g., LOS, hospital charges): Survey-weighted linear regression using the gaussian family\nResults reported as adjusted odds ratios (aORs) or beta coefficients with 95% confidence intervals\n\n\nSoftware: All statistical analyses were performed using the R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Cardiovascular Complications In Patients Undergoing Lung Transplantation: A National Inpatient Sample Study",
    "section": "",
    "text": "Study Objective: To evaluate the burden and outcomes of cardiovascular complications occurring during lung transplant hospitalization and identify patient- and hospital-level predictors associated with adverse clinical outcomes.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2017 to 2022. The NIS is part of the Healthcare Cost and Utilization Project (HCUP) and provides a stratified sample of inpatient discharges from U.S. community hospitals across all payers.\nCohort Definition: Patients were included if they met the following criteria\n\nAge ≥ 18 years\nUndergoing lung transplant (ICD 10 PCS: 0BYC0Z0, 0BYC0Z1, 0BYC0Z2, 0BYD0Z0, 0BYD0Z1, 0BYD0Z2, 0BYF0Z0, 0BYF0Z1, 0BYF0Z2, 0BYG0Z0, 0BYG0Z1, 0BYG0Z2, 0BYH0Z0, 0BYH0Z1, 0BYH0Z2, 0BYJ0Z0, 0BYJ0Z1, 0BYJ0Z2, 0BYK0Z0, 0BYK0Z1, 0BYK0Z2, 0BYL0Z0, 0BYL0Z1, 0BYL0Z2, 0BYM0Z0, 0BYM0Z1, 0BYM0Z2)\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nMACE (Acute myocardial infarction OR Cardiac arrest OR Cardiac arrest OR Ventricular arrhythmia OR Revascularization OR Mechanical circulatory support)\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2021 ($)\n\nSecondary Outcomes:\n\nAcute myocardial infarction\nIschemic stroke\nVentricular arrhythmia\nCardiogenic shock\nVenous thromboembolism\nMechanical circulatory support\nSepsis\nAcute kidney injury\nNon-home discharge\n\nCovariates for Adjustment: All models adjusted for the following:\n\nDemographics: Age, sex, race, income, insurance, location of patient’s residence, hospital region, and hospital bedsize\nMedical History: Chronic heart failure, diabetes mellitus, hypertension, chronic kidney disease, peripheral vascular disease, liver disease, valvular heart disease, anemia, and pulmonary circulatory disorders, grouped charlson comorbidity index.\n\nStatistical Methods:\n\nUnivariable Analysis:\n\nCategorical variables: Compared using Pearson’s chi-square test with Rao & Scott adjustment\nContinuous variables: Analyzed using the design-based Kruskal–Wallis test, a non-parametric alternative suitable for survey-weighted data\n\nMultivariable Analysis:\n\nBinary outcomes (e.g., mortality): Survey-weighted logistic regression using the quasibinomial family\nContinuous outcomes (e.g., LOS, hospital charges): Survey-weighted linear regression using the gaussian family\nResults reported as adjusted odds ratios (aORs) or beta coefficients with 95% confidence intervals\n\n\nSoftware: All statistical analyses were performed using the R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#descriptive-analysis",
    "href": "quarto/index.html#descriptive-analysis",
    "title": "Cardiovascular Complications In Patients Undergoing Lung Transplantation: A National Inpatient Sample Study",
    "section": "Descriptive analysis",
    "text": "Descriptive analysis\n\nBaseline Characteristics:\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nN = 15,1251\n\n\n\n\nAge, y\n62 (53, 67)\n\n\nSex\n\n\n\n\n    Female\n5,820 (38%)\n\n\n    Male\n9,305 (62%)\n\n\nRace\n\n\n\n\n    White\n10,945 (74%)\n\n\n    Black\n1,410 (9.5%)\n\n\n    Hispanic\n1,655 (11%)\n\n\n    Other\n875 (5.9%)\n\n\nResidential income\n\n\n\n\n    Q1\n2,710 (18%)\n\n\n    Q2\n3,840 (26%)\n\n\n    Q3\n4,020 (27%)\n\n\n    Q4\n4,330 (29%)\n\n\nInsurance\n\n\n\n\n    Private\n6,600 (44%)\n\n\n    Medicaid\n1,095 (7.2%)\n\n\n    Medicare\n7,030 (47%)\n\n\n    Other\n390 (2.6%)\n\n\nHospital region\n\n\n\n\n    Midwest\n3,835 (25%)\n\n\n    Northeast\n3,010 (20%)\n\n\n    South\n5,045 (33%)\n\n\n    West\n3,235 (21%)\n\n\nHospital bedsize\n\n\n\n\n    Large\n14,710 (97%)\n\n\n    Medium\n410 (2.7%)\n\n\n    Small\n5 (&lt;0.1%)\n\n\nHospital location and teaching status\n\n\n\n\n    Urban, teaching\n15,125 (100%)\n\n\nDiabetes mellitus\n2,825 (19%)\n\n\nHypertension\n905 (6.0%)\n\n\nChronic kidney disease\n1,290 (8.5%)\n\n\nPeripheral vascular disease\n865 (5.7%)\n\n\nChronic heart failure\n1,840 (12%)\n\n\nAnemia\n830 (5.5%)\n\n\nCancer\n285 (1.9%)\n\n\nPulmonary circulation disorders\n6,370 (42%)\n\n\nGrouped charlson comorbidity index\n\n\n\n\n    No comorbidities\n2,850 (19%)\n\n\n    One comorbidity\n6,070 (40%)\n\n\n    Two or more comorbidities\n6,205 (41%)\n\n\n\n1 Median (Q1, Q3); n (%)\n\n\n\n\n\n\n\n\n\n\nOutcomes Table:\n\n\n\n\n\n\n\n\nCharacteristic\nN = 15,1251\n\n\n\n\nDied during hospitalization\n750 (5.0%)\n\n\nLength of stay (days)\n22 (14, 43)\n\n\nInflation-adjusted total charge ($)\n784,700 (525,851, 1,395,127)\n\n\nMajor adverse cardiovascular events\n5,550 (37%)\n\n\nAcute myocardial infarction\n290 (1.9%)\n\n\nIschemic stroke\n485 (3.2%)\n\n\nAcute kidney injury\n7,040 (47%)\n\n\nCardiogenic shock\n1,500 (9.9%)\n\n\nVentricular arrhythmias\n800 (5.3%)\n\n\nVenous thromboembolism\n3,765 (25%)\n\n\nSepsis\n1,895 (13%)\n\n\nMechanical circulatory support\n3,740 (25%)\n\n\nNon-home discharge\n830 (5.5%)\n\n\n\n1 n (%); Median (Q1, Q3)"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Cardiovascular Complications In Patients Undergoing Lung Transplantation: A National Inpatient Sample Study",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nIn-hospital mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.81\n0.56, 1.19\n0.3\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.01\n0.57, 1.79\n&gt;0.9\n\n\n    Hispanic\n1.08\n0.60, 1.93\n0.8\n\n\n    Other\n1.48\n0.71, 3.07\n0.3\n\n\nAge, y\n1.00\n0.99, 1.02\n0.7\n\n\nResidential income\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n0.67\n0.41, 1.08\n0.10\n\n\n    Q3\n0.75\n0.47, 1.21\n0.2\n\n\n    Q4\n0.72\n0.43, 1.21\n0.2\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.76\n0.36, 1.63\n0.5\n\n\n    Medicare\n1.08\n0.73, 1.61\n0.7\n\n\n    Other\n0.74\n0.24, 2.22\n0.6\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.79\n0.46, 1.36\n0.4\n\n\n    South\n1.13\n0.73, 1.72\n0.6\n\n\n    West\n0.84\n0.47, 1.52\n0.6\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.66\n0.21, 2.04\n0.5\n\n\n    Small\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nGrouped charlson comorbidity index\n\n\n\n\n\n\n\n\n    No comorbidities\n—\n—\n\n\n\n\n    One comorbidity\n1.05\n0.62, 1.79\n0.8\n\n\n    Two or more comorbidities\n1.01\n0.53, 1.91\n&gt;0.9\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.38, 1.64\n0.5\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.65\n0.38, 1.12\n0.12\n\n\nChronic heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.68\n1.06, 2.67\n0.028\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.57\n1.42, 4.66\n0.002\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.71\n0.87, 3.36\n0.12\n\n\nLiver_Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n6.11\n3.93, 9.50\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.62\n0.27, 1.43\n0.3\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.93\n0.65, 1.34\n0.7\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nMajor Adverse Cardiovascular Events:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.23\n1.03, 1.47\n0.021\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.51\n1.13, 2.01\n0.005\n\n\n    Hispanic\n1.65\n1.27, 2.13\n&lt;0.001\n\n\n    Other\n1.70\n1.28, 2.27\n&lt;0.001\n\n\nAge, y\n0.98\n0.98, 0.99\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n1.29\n1.00, 1.67\n0.050\n\n\n    Q3\n1.23\n0.94, 1.62\n0.13\n\n\n    Q4\n1.31\n1.02, 1.69\n0.032\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.91\n0.66, 1.25\n0.5\n\n\n    Medicare\n0.84\n0.70, 1.00\n0.049\n\n\n    Other\n0.77\n0.48, 1.23\n0.3\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.17\n0.90, 1.51\n0.2\n\n\n    South\n0.93\n0.71, 1.22\n0.6\n\n\n    West\n0.89\n0.66, 1.19\n0.4\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.34\n0.76, 2.34\n0.3\n\n\n    Small\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nGrouped charlson comorbidity index\n\n\n\n\n\n\n\n\n    No comorbidities\n—\n—\n\n\n\n\n    One comorbidity\n0.92\n0.74, 1.14\n0.5\n\n\n    Two or more comorbidities\n1.10\n0.85, 1.43\n0.5\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.53, 1.31\n0.4\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.75\n0.59, 0.95\n0.019\n\n\nChronic heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.70\n1.32, 2.20\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.18\n0.83, 1.67\n0.4\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.19\n0.83, 1.71\n0.3\n\n\nLiver_Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.56\n1.17, 2.09\n0.003\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.66\n0.47, 0.94\n0.021\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.11\n0.93, 1.31\n0.2\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nAcute Myocardial Infarction:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.24\n0.71, 2.18\n0.5\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.31\n0.57, 3.00\n0.5\n\n\n    Hispanic\n0.89\n0.33, 2.40\n0.8\n\n\n    Other\n2.28\n0.89, 5.82\n0.086\n\n\nAge, y\n1.04\n1.01, 1.07\n0.022\n\n\nResidential income\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n0.72\n0.31, 1.69\n0.5\n\n\n    Q3\n0.62\n0.26, 1.51\n0.3\n\n\n    Q4\n1.38\n0.63, 2.99\n0.4\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.28\n0.04, 2.01\n0.2\n\n\n    Medicare\n0.84\n0.45, 1.56\n0.6\n\n\n    Other\n0.80\n0.11, 5.98\n0.8\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.38\n0.56, 3.35\n0.5\n\n\n    South\n1.41\n0.65, 3.05\n0.4\n\n\n    West\n0.74\n0.30, 1.83\n0.5\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n    Small\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nGrouped charlson comorbidity index\n\n\n\n\n\n\n\n\n    No comorbidities\n—\n—\n\n\n\n\n    One comorbidity\n10,370,615\n4,760,398, 22,592,578\n&lt;0.001\n\n\n    Two or more comorbidities\n69,338,635\n41,285,436, 116,453,810\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.57\n0.12, 2.69\n0.5\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.28\n0.12, 0.67\n0.004\n\n\nChronic heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.60\n0.22, 1.58\n0.3\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.48\n0.14, 1.61\n0.2\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.53\n0.18, 1.58\n0.3\n\n\nLiver_Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.74\n0.29, 1.84\n0.5\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.31\n0.04, 2.35\n0.3\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.48, 1.46\n0.5\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nIschemic Stroke:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.70\n0.45, 1.07\n0.095\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n0.75\n0.34, 1.64\n0.5\n\n\n    Hispanic\n1.44\n0.76, 2.72\n0.3\n\n\n    Other\n0.55\n0.15, 1.96\n0.4\n\n\nAge, y\n1.01\n0.99, 1.03\n0.4\n\n\nResidential income\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n0.57\n0.29, 1.09\n0.089\n\n\n    Q3\n0.91\n0.46, 1.78\n0.8\n\n\n    Q4\n1.05\n0.56, 1.96\n0.9\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.27\n0.60, 2.73\n0.5\n\n\n    Medicare\n0.69\n0.43, 1.11\n0.13\n\n\n    Other\n0.37\n0.05, 2.91\n0.3\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.05\n0.55, 1.99\n0.9\n\n\n    South\n1.19\n0.68, 2.06\n0.5\n\n\n    West\n0.89\n0.47, 1.67\n0.7\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.37\n0.06, 2.45\n0.3\n\n\n    Small\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nGrouped charlson comorbidity index\n\n\n\n\n\n\n\n\n    No comorbidities\n—\n—\n\n\n\n\n    One comorbidity\n6,053,683\n3,699,125, 9,906,958\n&lt;0.001\n\n\n    Two or more comorbidities\n38,968,891\n25,908,833, 58,612,229\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.41, 2.06\n0.8\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.27\n0.14, 0.51\n&lt;0.001\n\n\nChronic heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.64\n0.34, 1.18\n0.2\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.55\n0.25, 1.17\n0.12\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.31\n0.11, 0.92\n0.034\n\n\nLiver_Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.42\n0.83, 2.44\n0.2\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.36\n0.08, 1.57\n0.2\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.72\n0.45, 1.16\n0.2\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nCardiogenic Shock:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.19\n0.92, 1.54\n0.2\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.13\n0.72, 1.77\n0.6\n\n\n    Hispanic\n1.38\n0.93, 2.05\n0.11\n\n\n    Other\n1.27\n0.78, 2.06\n0.3\n\n\nAge, y\n0.99\n0.98, 1.00\n0.007\n\n\nResidential income\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n1.02\n0.70, 1.49\n&gt;0.9\n\n\n    Q3\n1.22\n0.83, 1.81\n0.3\n\n\n    Q4\n1.16\n0.77, 1.74\n0.5\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.83\n0.52, 1.31\n0.4\n\n\n    Medicare\n0.91\n0.68, 1.23\n0.5\n\n\n    Other\n0.47\n0.19, 1.15\n0.10\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.12\n0.70, 1.80\n0.6\n\n\n    South\n0.98\n0.69, 1.40\n&gt;0.9\n\n\n    West\n1.35\n0.86, 2.13\n0.2\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.82\n0.35, 1.91\n0.6\n\n\n    Small\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nGrouped charlson comorbidity index\n\n\n\n\n\n\n\n\n    No comorbidities\n—\n—\n\n\n\n\n    One comorbidity\n1.07\n0.75, 1.54\n0.7\n\n\n    Two or more comorbidities\n1.15\n0.79, 1.67\n0.5\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.57\n0.24, 1.32\n0.2\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.65\n0.45, 0.94\n0.021\n\n\nChronic heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.99\n1.43, 2.77\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.45\n0.81, 2.60\n0.2\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.53, 1.60\n0.8\n\n\nLiver_Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.25\n1.58, 3.20\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.46, 1.50\n0.5\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.16\n0.88, 1.52\n0.3\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nVentricular Arrhythmias:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.48\n1.01, 2.16\n0.045\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.87\n1.10, 3.18\n0.020\n\n\n    Hispanic\n1.55\n0.96, 2.50\n0.072\n\n\n    Other\n0.85\n0.38, 1.92\n0.7\n\n\nAge, y\n1.01\n1.00, 1.03\n0.083\n\n\nResidential income\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n1.29\n0.71, 2.34\n0.4\n\n\n    Q3\n1.21\n0.69, 2.15\n0.5\n\n\n    Q4\n1.26\n0.72, 2.21\n0.4\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.16\n0.57, 2.38\n0.7\n\n\n    Medicare\n1.07\n0.75, 1.54\n0.7\n\n\n    Other\n1.46\n0.57, 3.75\n0.4\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.76\n0.41, 1.43\n0.4\n\n\n    South\n0.94\n0.58, 1.53\n0.8\n\n\n    West\n1.40\n0.89, 2.21\n0.15\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.45\n0.59, 3.61\n0.4\n\n\n    Small\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nGrouped charlson comorbidity index\n\n\n\n\n\n\n\n\n    No comorbidities\n—\n—\n\n\n\n\n    One comorbidity\n0.97\n0.62, 1.54\n&gt;0.9\n\n\n    Two or more comorbidities\n1.28\n0.77, 2.14\n0.3\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.43, 1.64\n0.6\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.75\n0.48, 1.19\n0.2\n\n\nChronic heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.66\n0.38, 1.13\n0.13\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.21\n0.68, 2.16\n0.5\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.76\n0.96, 3.22\n0.068\n\n\nLiver_Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.45\n0.86, 2.47\n0.2\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.61\n0.24, 1.58\n0.3\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.78\n0.55, 1.10\n0.2\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nVenous Thromboembolism:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.20\n1.01, 1.43\n0.043\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.34\n1.02, 1.76\n0.036\n\n\n    Hispanic\n1.50\n1.14, 1.98\n0.004\n\n\n    Other\n0.98\n0.66, 1.44\n&gt;0.9\n\n\nAge, y\n0.98\n0.97, 0.99\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n0.99\n0.75, 1.31\n&gt;0.9\n\n\n    Q3\n1.06\n0.81, 1.39\n0.7\n\n\n    Q4\n1.12\n0.86, 1.46\n0.4\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.93\n0.64, 1.35\n0.7\n\n\n    Medicare\n0.97\n0.80, 1.18\n0.8\n\n\n    Other\n1.47\n0.89, 2.43\n0.13\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.26\n0.95, 1.67\n0.11\n\n\n    South\n1.17\n0.86, 1.57\n0.3\n\n\n    West\n0.72\n0.50, 1.02\n0.066\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n2.25\n1.01, 4.99\n0.046\n\n\n    Small\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nGrouped charlson comorbidity index\n\n\n\n\n\n\n\n\n    No comorbidities\n—\n—\n\n\n\n\n    One comorbidity\n0.93\n0.72, 1.20\n0.6\n\n\n    Two or more comorbidities\n1.03\n0.75, 1.40\n0.9\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.91\n0.56, 1.48\n0.7\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.95\n0.73, 1.24\n0.7\n\n\nChronic heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.21\n0.91, 1.59\n0.2\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.10\n0.72, 1.68\n0.7\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.76\n1.25, 2.48\n0.001\n\n\nLiver_Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.88\n0.64, 1.21\n0.4\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.70\n0.47, 1.03\n0.073\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.09\n0.92, 1.31\n0.3\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nSepsis:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.06\n0.83, 1.34\n0.7\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.03\n0.68, 1.58\n0.9\n\n\n    Hispanic\n1.67\n1.12, 2.49\n0.013\n\n\n    Other\n0.97\n0.60, 1.58\n&gt;0.9\n\n\nAge, y\n0.98\n0.97, 0.99\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n1.16\n0.84, 1.62\n0.4\n\n\n    Q3\n1.00\n0.70, 1.42\n&gt;0.9\n\n\n    Q4\n1.19\n0.84, 1.69\n0.3\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.50\n0.29, 0.86\n0.012\n\n\n    Medicare\n0.94\n0.73, 1.21\n0.6\n\n\n    Other\n0.72\n0.34, 1.51\n0.4\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.91\n0.64, 1.30\n0.6\n\n\n    South\n0.87\n0.61, 1.23\n0.4\n\n\n    West\n0.93\n0.62, 1.40\n0.7\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.86\n0.44, 1.70\n0.7\n\n\n    Small\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nGrouped charlson comorbidity index\n\n\n\n\n\n\n\n\n    No comorbidities\n—\n—\n\n\n\n\n    One comorbidity\n0.85\n0.62, 1.19\n0.3\n\n\n    Two or more comorbidities\n0.96\n0.65, 1.43\n0.8\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.55\n0.29, 1.02\n0.058\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.55\n0.38, 0.79\n0.001\n\n\nChronic heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.07\n0.75, 1.52\n0.7\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.39\n1.47, 3.88\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.38\n0.83, 2.30\n0.2\n\n\nLiver_Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.44\n1.68, 3.56\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.59, 1.62\n&gt;0.9\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.56\n0.43, 0.72\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nAcute Kidney Injury:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.23\n1.05, 1.43\n0.011\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.66\n1.28, 2.16\n&lt;0.001\n\n\n    Hispanic\n0.83\n0.64, 1.07\n0.15\n\n\n    Other\n0.87\n0.62, 1.22\n0.4\n\n\nAge, y\n0.99\n0.98, 1.00\n0.062\n\n\nResidential income\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n1.06\n0.85, 1.33\n0.6\n\n\n    Q3\n1.12\n0.88, 1.43\n0.3\n\n\n    Q4\n1.24\n0.99, 1.55\n0.057\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.09\n0.80, 1.49\n0.6\n\n\n    Medicare\n1.06\n0.89, 1.26\n0.5\n\n\n    Other\n0.83\n0.50, 1.39\n0.5\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.18\n0.89, 1.58\n0.2\n\n\n    South\n0.75\n0.60, 0.95\n0.017\n\n\n    West\n0.99\n0.77, 1.27\n&gt;0.9\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.98\n0.68, 1.41\n&gt;0.9\n\n\n    Small\n234,788\n31,779, 1,734,657\n&lt;0.001\n\n\nGrouped charlson comorbidity index\n\n\n\n\n\n\n\n\n    No comorbidities\n—\n—\n\n\n\n\n    One comorbidity\n1.00\n0.80, 1.25\n&gt;0.9\n\n\n    Two or more comorbidities\n1.05\n0.81, 1.36\n0.7\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.45\n0.96, 2.18\n0.074\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.73, 1.16\n0.5\n\n\nChronic heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.57\n1.22, 2.01\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3.19\n2.20, 4.62\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.04\n0.72, 1.51\n0.8\n\n\nLiver_Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.90\n1.43, 2.52\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.71, 1.40\n&gt;0.9\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.88\n0.75, 1.04\n0.13\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nMechanical Circulatory Support:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.07\n0.88, 1.29\n0.5\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.64\n1.21, 2.22\n0.002\n\n\n    Hispanic\n1.68\n1.29, 2.18\n&lt;0.001\n\n\n    Other\n1.72\n1.23, 2.41\n0.002\n\n\nAge, y\n0.98\n0.97, 0.98\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n1.20\n0.92, 1.55\n0.2\n\n\n    Q3\n1.15\n0.86, 1.53\n0.3\n\n\n    Q4\n1.22\n0.93, 1.59\n0.15\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.97\n0.69, 1.37\n0.9\n\n\n    Medicare\n0.85\n0.70, 1.02\n0.087\n\n\n    Other\n0.85\n0.50, 1.45\n0.6\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.21\n0.87, 1.68\n0.3\n\n\n    South\n1.01\n0.73, 1.38\n&gt;0.9\n\n\n    West\n0.68\n0.47, 0.98\n0.039\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.13\n0.59, 2.15\n0.7\n\n\n    Small\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nGrouped charlson comorbidity index\n\n\n\n\n\n\n\n\n    No comorbidities\n—\n—\n\n\n\n\n    One comorbidity\n0.76\n0.60, 0.96\n0.023\n\n\n    Two or more comorbidities\n0.78\n0.58, 1.05\n0.10\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.85\n0.50, 1.43\n0.5\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.93\n0.70, 1.23\n0.6\n\n\nChronic heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.59\n1.21, 2.10\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.18\n0.80, 1.74\n0.4\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.29\n0.86, 1.92\n0.2\n\n\nLiver_Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.50\n1.10, 2.04\n0.011\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.55, 1.17\n0.3\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.20\n0.98, 1.47\n0.080\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nNon-Home Discharge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.87\n0.60, 1.25\n0.5\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.04\n0.60, 1.81\n0.9\n\n\n    Hispanic\n1.14\n0.68, 1.90\n0.6\n\n\n    Other\n1.34\n0.67, 2.68\n0.4\n\n\nAge, y\n1.01\n0.99, 1.03\n0.2\n\n\nResidential income\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n0.75\n0.48, 1.17\n0.2\n\n\n    Q3\n0.69\n0.43, 1.10\n0.11\n\n\n    Q4\n0.68\n0.41, 1.13\n0.14\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.75\n0.36, 1.58\n0.4\n\n\n    Medicare\n0.88\n0.59, 1.31\n0.5\n\n\n    Other\n2.57\n0.94, 7.02\n0.065\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.66\n0.39, 1.12\n0.12\n\n\n    South\n0.91\n0.60, 1.38\n0.7\n\n\n    West\n0.90\n0.52, 1.57\n0.7\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.62\n0.20, 1.93\n0.4\n\n\n    Small\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nGrouped charlson comorbidity index\n\n\n\n\n\n\n\n\n    No comorbidities\n—\n—\n\n\n\n\n    One comorbidity\n1.15\n0.70, 1.89\n0.6\n\n\n    Two or more comorbidities\n0.84\n0.45, 1.58\n0.6\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.82\n0.41, 1.65\n0.6\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.48, 1.33\n0.4\n\n\nChronic heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.57\n0.99, 2.49\n0.056\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.64\n1.46, 4.76\n0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.66\n0.84, 3.31\n0.15\n\n\nLiver_Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5.88\n3.84, 9.00\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.56\n0.24, 1.28\n0.2\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.69, 1.38\n0.9\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Cardiovascular Complications In Patients Undergoing Lung Transplantation: A National Inpatient Sample Study",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.21\n-2.9, 3.3\n0.9\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n3.6\n-0.98, 8.2\n0.12\n\n\n    Hispanic\n8.9\n3.3, 14\n0.002\n\n\n    Other\n2.5\n-3.1, 8.1\n0.4\n\n\nAge, y\n-0.31\n-0.46, -0.16\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n-1.5\n-5.8, 2.7\n0.5\n\n\n    Q3\n-2.9\n-7.5, 1.7\n0.2\n\n\n    Q4\n-0.70\n-5.5, 4.1\n0.8\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-1.6\n-7.5, 4.3\n0.6\n\n\n    Medicare\n-0.17\n-3.6, 3.3\n&gt;0.9\n\n\n    Other\n-1.2\n-10, 8.0\n0.8\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n-0.51\n-4.7, 3.7\n0.8\n\n\n    South\n-1.2\n-5.4, 3.0\n0.6\n\n\n    West\n-3.9\n-8.3, 0.52\n0.084\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n8.3\n-1.8, 18\n0.11\n\n\n    Small\n9.1\n4.0, 14\n&lt;0.001\n\n\nGrouped charlson comorbidity index\n\n\n\n\n\n\n\n\n    No comorbidities\n—\n—\n\n\n\n\n    One comorbidity\n-1.5\n-4.8, 1.9\n0.4\n\n\n    Two or more comorbidities\n6.2\n1.3, 11\n0.013\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-16\n-26, -6.1\n0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-7.1\n-11, -3.3\n&lt;0.001\n\n\nChronic heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.4\n-3.0, 7.8\n0.4\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n25\n13, 36\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.92\n-7.7, 5.9\n0.8\n\n\nLiver_Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n8.7\n1.9, 16\n0.012\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n8.5\n1.0, 16\n0.026\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-4.4\n-7.7, -1.1\n0.008\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nTotal hospital charges:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n9,728\n-80,621, 100,077\n0.8\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n97,583\n-42,280, 237,446\n0.2\n\n\n    Hispanic\n423,521\n167,744, 679,298\n0.001\n\n\n    Other\n56,298\n-99,924, 212,520\n0.5\n\n\nAge, y\n-13,043\n-17,707, -8,379\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n-21,806\n-136,428, 92,817\n0.7\n\n\n    Q3\n-107,898\n-240,635, 24,839\n0.11\n\n\n    Q4\n11,577\n-134,989, 158,143\n0.9\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n110,561\n-87,339, 308,462\n0.3\n\n\n    Medicare\n50,737\n-32,654, 134,128\n0.2\n\n\n    Other\n99,712\n-217,311, 416,735\n0.5\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n701,086\n520,831, 881,341\n&lt;0.001\n\n\n    South\n41,431\n-77,008, 159,870\n0.5\n\n\n    West\n577,630\n330,767, 824,493\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-35,641\n-321,634, 250,351\n0.8\n\n\n    Small\n195,896\n50,541, 341,250\n0.008\n\n\nGrouped charlson comorbidity index\n\n\n\n\n\n\n\n\n    No comorbidities\n—\n—\n\n\n\n\n    One comorbidity\n-139,550\n-255,770, -23,331\n0.019\n\n\n    Two or more comorbidities\n30,259\n-129,583, 190,101\n0.7\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-302,181\n-525,763, -78,598\n0.008\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-249,333\n-359,114, -139,551\n&lt;0.001\n\n\nChronic heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n136,510\n1,807, 271,213\n0.047\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n412,239\n163,316, 661,161\n0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n134,709\n-92,261, 361,679\n0.2\n\n\nLiver_Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n364,459\n154,408, 574,510\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n16,871\n-146,998, 180,740\n0.8\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-131,821\n-220,691, -42,951\n0.004\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]